FIRST AMENDMENT TO RESEARCH COLLABORATION AND LICENSE AGREEMENTResearch Collaboration and License Agreement • March 2nd, 2005 • Arena Pharmaceuticals Inc • Pharmaceutical preparations
This FIRST AMENDMENT TO RESEARCH COLLABORATION AND LICENSE AGREEMENT (this “First Amendment”) dated as of October 20, 2004, is entered into by and between Merck & Co., Inc. (“MERCK”) and ARENA PHARMACEUTICALS, INC., (“ARENA”) and amends that certain Research Collaboration and License Agreement between MERCK and ARENA, effective as of October 21, 2002 (the “Agreement”).
COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • March 2nd, 2005 • Arena Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS COLLABORATION AND LICENSE AGREEMENT (this “Agreement”) is entered into as of December 20, 2004 (the “Effective Date”) by and between ARENA PHARMACEUTICALS, INC., a Delaware corporation having an office at 6166 Nancy Ridge Drive, San Diego, CA 92121 (“Arena”), and ORTHO-MCNEIL PHARMACEUTICAL, INC., a New Jersey corporation having an office at 1000 U.S. Route 202, Raritan, New Jersey 08869 (“J&J”). Arena and J&J may each be referred to individually as a “Party”, and collectively as the “Parties”.
